Viewing Study NCT00079157


Ignite Creation Date: 2025-12-24 @ 7:00 PM
Ignite Modification Date: 2025-12-30 @ 2:37 AM
Study NCT ID: NCT00079157
Status: COMPLETED
Last Update Posted: 2020-02-05
First Post: 2004-03-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Vaccine Plus Montanide ISA-51 and Sargramostim in Treating Patients With Stage IV Breast Cancer
Sponsor: Abramson Cancer Center at Penn Medicine
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module